Article Text

PDF
Outcome after redo coronary artery bypass grafting in patients with ischaemic cardiomyopathy and viable myocardium
  1. V Rizzello1,
  2. D Poldermans1,
  3. A F L Schinkel1,
  4. E Biagini1,
  5. E Boersma1,
  6. A Elhendy1,
  7. F B Sozzi1,
  8. A Palazzuoli1,
  9. A Maat1,
  10. F Crea2,
  11. J J Bax3
  1. 1Department of Cardiology, Thorax Center, Erasmus MC, Rotterdam, The Netherlands
  2. 2The Catholic University of the Sacred Heart, Rome, Italy
  3. 3The Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
  1. Correspondence to:
    Dr D Poldermans
    Department of Cardiology, Thorax Center Room Ba 300, Erasmus MC, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands; d.poldermans{at}erasmusmc.nl

Abstract

Background: Repeat coronary artery bypass grafting (redo-CABG) in patients with ischaemic cardiomyopathy is associated with high perioperative risk and worse long-term outcome compared with patients undergoing their first CABG.

Objective: To assess whether patients with viable myocardium undergoing redo-CABG have a better outcome.

Methods: 18 patients with ischaemic cardiomyopathy underwent redo-CABG and 34 underwent their first CABG; all had substantial viability (⩾25% of the left ventricle) on dobutamine stress echocardiography (DSE). Left ventricular ejection fraction (LVEF) and heart failure symptoms were assessed before and 9–12 months after revascularisation. Cardiac event rate was assessed during the follow-up period (median 4 years, 25–75th centile 2.8–4.9 years).

Results: The extent of viable myocardium on DSE was comparable in the two groups (11.3 (3.9) segments in patients who underwent redo-CABG v 12.8 (3.0) in patients who underwent their first CABG; p = NS). LVEF improved from 32% (9%) to 39% (12%); p = 0.01, in patients who underwent redo-CABG and from 30% (7%) to 36% (7%); p<0.01, in those who underwent their first CABG; New York Heart Association class improved from 2.5 (1.1) to 1.9 (0.8); p = 0.03, and from 2.7 (1.0) to 1.8 (0.70); p<0.01, respectively. In patients who underwent redo-CABG, the perioperative mortality was 0, post-surgery inotropic support was needed in 11% of the patients and mid-term (4-year) survival was 100%, with a total event rate of 28%. All these variables were not statistically different from patients who underwent their first CABG (p = 0.50, 0.90, 0.08 and 0.81, respectively).

Conclusion: Patients with ischaemic cardiomyopathy and substantial viability undergoing redo-CABG benefit from revascularisation in terms of improvement in LVEF, heart failure symptoms, angina and mid-term prognosis.

  • CCS, Canadian Cardiovascular Society
  • DSE, dobutamine stress echocardiography
  • LVEF, left ventricular ejection fraction
  • NYHA, New York Heart Association
  • redo-CABG, repeat coronary artery bypass grafting

Statistics from Altmetric.com

Footnotes

  • Published Online First 11 August 2006

  • Competing interests: None declared.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.